No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10856-E10858. doi: 10.1073/pnas.1716644115. Epub 2017 Dec 12.

Authors

Sofie Mohlin¹, Kristoffer von Stedingk¹, Alexander Pietras², Sven Påhlman³

Affiliations

¹ Department of Pediatrics, Clinical Sciences, Lund University, 22185 Lund, Sweden.
² Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, 22381 Lund, Sweden.
³ Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, 22381 Lund, Sweden sven.pahlman@med.lu.se.

No abstract available

Publication types

Letter
Comment

MeSH terms

Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Humans
Hypoxia-Inducible Factor 1, alpha Subunit / genetics
Neuroblastoma / genetics*
Oncogenes*

Substances

Hypoxia-Inducible Factor 1, alpha Subunit